Latest Shareholder Approval News

Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.

Neurizon Therapeutics has locked in a $44 million funding package to fully support its lead drug NUZ-001 in the HEALEY ALS Platform Trial, marking a critical step toward potential regulatory approval and broader neurodegenerative applications.

OZZ Resources has entered a binding option agreement with Scorpion Minerals, offering an exclusive chance to acquire its key tenements for $2.6 million plus a gold production royalty. The deal awaits shareholder approval and hinges on several regulatory and operational conditions.

Rox Resources has completed a $200 million capital raise, including a $134 million second tranche placement, to fund development of its Youanmi Gold Project in Western Australia.

Minbos Resources has obtained a crucial ASX waiver allowing it to issue shares under its Share Purchase Plan without the usual shareholder approval, aligning pricing with its recent Placement and aiming to maintain fairness among investors.

Hartshead Resources NL has entered a binding agreement for acquisition by ACAM GP Limited, offering shareholders a 133% premium and a clear exit from development risks. The scheme is set for implementation in early 2026, pending approvals.

Tempest Minerals has agreed to sell its Yalgoo Project to Capricorn Metals for $4.5 million in cash and shares, with additional payments tied to future discoveries and production milestones. The deal, expected to complete in early 2026, leaves Tempest retaining iron rights on key tenements while refocusing on other Western Australian assets.

Lithium Universe Limited has completed the second tranche of its share placement, raising $40,000 and issuing over 56 million listed options, as it pushes forward with lithium refinery projects in Québec and Texas.

Seven West Media shareholders have overwhelmingly approved the proposed acquisition by Southern Cross Media Group, clearing a major hurdle ahead of final court approval.

Global Uranium and Enrichment Limited (GUE) has registered its scheme booklet with ASIC, detailing the proposed acquisition by Snow Lake Resources Ltd. The independent expert report supports the fairness and reasonableness of the deal, with GUE directors unanimously recommending shareholder approval.

Seven West Media shareholders have overwhelmingly approved the proposed acquisition by Southern Cross Media Group, clearing a major hurdle ahead of final court approval.

CONNEQT Health has raised $3.1 million through an institutional placement to fuel growth of its Pulse vascular health device, supported by both new and existing investors including its largest shareholder.